Y-mAbs Therapeutics, Inc.
US ˙ NasdaqGS ˙ US9842411095

Pendahuluan

Halaman ini memberikan analisis komprehensif tentang sejarah perdagangan orang dalam yang diketahui dari Thomas Gad. Orang dalam adalah pejabat, direktur, atau investor signifikan dalam suatu perusahaan. Adalah ilegal bagi orang dalam untuk melakukan perdagangan di perusahaan mereka berdasarkan informasi spesifik yang tidak dipublikasikan. Ini tidak berarti bahwa mereka dilarang melakukan perdagangan apa pun di perusahaan mereka sendiri. Namun, mereka harus melaporkan semua perdagangan kepada SEC melalui Formulir 4. Terlepas dari pembatasan ini, penelitian akademis menunjukkan bahwa orang dalam - secara umum - cenderung mengungguli pasar di perusahaan mereka sendiri.

Rata-rata Profitabilitas Perdagangan

Profitabilitas perdagangan rata-rata adalah pengembalian rata-rata dari semua pembelian pasar terbuka yang dilakukan oleh orang dalam dalam tiga tahun terakhir. Untuk menghitung ini, kami memeriksa setiap pembelian pasar terbuka yang tidak direncanakan yang dilakukan oleh orang dalam, tidak termasuk semua perdagangan yang ditandai sebagai bagian dari rencana perdagangan 10b5-1. Kami kemudian menghitung kinerja rata-rata dari perdagangan tersebut selama 3, 6, dan 12 bulan, dengan merata-ratakan setiap durasi tersebut untuk menghasilkan metrik kinerja akhir untuk setiap perdagangan. Terakhir, kami merata-ratakan semua metrik kinerja untuk menghitung metrik kinerja untuk orang dalam. Daftar ini hanya mencakup orang dalam yang telah melakukan setidaknya tiga perdagangan dalam dua tahun terakhir.

Jika profitabilitas perdagangan orang dalam ini adalah "N/A", maka orang dalam tersebut belum melakukan pembelian di pasar terbuka dalam tiga tahun terakhir, atau perdagangan yang mereka lakukan terlalu baru untuk menghitung metrik kinerja yang andal.

Frekuensi Pembaruan: Setiap Hari

Lihat daftar pedagang dalam perusahaan yang paling menguntungkan.

Perusahaan dengan Posisi Orang Dalam yang Dilaporkan

Pengajuan SEC menunjukkan bahwa Thomas Gad telah melaporkan kepemilikan atau perdagangan di perusahaan-perusahaan berikut:

Keamanan Judul Kepemilikan Terakhir yang Dilaporkan
US:YMAB / Y-mAbs Therapeutics, Inc. CHIEF BUSINESS OFFICER, Director 305,721
Cara Membaca Grafik

Grafik berikut menunjukkan kinerja saham sekuritas setelah setiap perdagangan pasar terbuka yang tidak direncanakan yang dilakukan oleh Thomas Gad. Perdagangan yang tidak direncanakan adalah perdagangan yang tidak dilakukan sebagai bagian dari rencana perdagangan 10b5-1. Kinerja saham digambarkan sebagai perubahan persentase kumulatif dalam harga saham. Misalnya, jika perdagangan orang dalam dilakukan pada 1 Januari 2019, grafik akan menunjukkan perubahan persentase harian sekuritas hingga saat ini. Jika harga saham naik dari $10 menjadi $15 selama periode ini, perubahan persentase kumulatif dalam harga saham akan menjadi 50%. Perubahan harga dari $10 menjadi $20 akan menjadi 100%, dan perubahan harga dari $10 menjadi $5 akan menjadi -50%.

Pada akhirnya, kita mencoba menentukan seberapa erat korelasi perdagangan orang dalam dengan pengembalian berlebih (positif atau negatif) pada harga saham untuk melihat apakah orang dalam tersebut mengatur waktu perdagangannya untuk mendapatkan keuntungan dari informasi orang dalam. Pertimbangkan situasi di mana orang dalam melakukan hal ini. Dalam situasi ini, kita akan mengharapkan (a) pengembalian positif setelah pembelian, atau (b) pengembalian negatif setelah penjualan. Dalam kasus (a), grafik PEMBELIAN akan menunjukkan serangkaian kurva yang miring ke atas, menunjukkan pengembalian positif setelah setiap transaksi pembelian. Dalam kasus (b), grafik PENJUALAN akan menunjukkan serangkaian kurva yang miring ke bawah, menunjukkan pengembalian negatif setelah setiap transaksi penjualan.

Namun, ini saja tidak cukup untuk menarik kesimpulan. Jika, misalnya, harga saham perusahaan berada dalam tren kenaikan non-siklikal selama bertahun-tahun, maka kita akan mengharapkan semua plot pasca-pembelian memiliki kemiringan ke atas. Demikian pula, penurunan non-siklikal selama bertahun-tahun akan menghasilkan plot pasca-perdagangan dengan kemiringan ke bawah. Tak satu pun dari grafik ini akan menunjukkan aktivitas perdagangan orang dalam.

Indikator terkuat adalah situasi di mana harga saham sangat siklikal, dan terdapat sinyal positif pada grafik PEMBELIAN dan plot negatif pada grafik PENJUALAN. Situasi ini akan sangat menunjukkan adanya orang dalam yang mengatur waktu perdagangan untuk keuntungan finansial mereka.

Pembelian Orang Dalam YMAB / Y-mAbs Therapeutics, Inc. - Analisis Keuntungan Jangka Pendek

Pada bagian ini, kami menganalisis profitabilitas setiap pembelian saham oleh orang dalam di pasar terbuka yang tidak direncanakan yang dilakukan di YMAB / Y-mAbs Therapeutics, Inc.. Analisis ini membantu memahami apakah orang dalam tersebut secara konsisten menghasilkan pengembalian abnormal, dan layak untuk diikuti. Analisis ini dilakukan selama satu tahun setelah setiap transaksi, dan hasilnya bersifat teoritis .

Tabel berikut menunjukkan pembelian pasar terbuka terbaru yang bukan bagian dari rencana perdagangan otomatis.

Tanggal Perdagangan Ticker Orang Dalam Dilaporkan
Saham
Dilaporkan
Harga
Disesuaikan
Saham
Disesuaikan
Harga
Dasar Biaya Hari-hari menuju
Maksimal
Harga di
Maksimal
Maksimal
Keuntungan ($)
Maksimum Pengembalian (%)
Tidak ada transaksi pasar terbuka tak terduga yang diketahui untuk kombinasi orang dalam dan sekuritas ini.

Harga yang Disesuaikan adalah harga yang disesuaikan dengan pemisahan saham. Saham yang Disesuaikan adalah saham yang disesuaikan dengan pemisahan saham.

YMAB / Y-mAbs Therapeutics, Inc. Insider Trades
Penjualan Orang Dalam YMAB / Y-mAbs Therapeutics, Inc. - Analisis Kerugian Jangka Pendek

Pada bagian ini, kami menganalisis penghindaran kerugian jangka pendek dari setiap penjualan internal pasar terbuka yang tidak direncanakan yang dilakukan di YMAB / Y-mAbs Therapeutics, Inc.. Pola penghindaran kerugian yang konsisten dapat menunjukkan bahwa transaksi penjualan di masa mendatang dapat memprediksi penurunan harga. Analisis ini berlaku untuk satu tahun setelah setiap perdagangan, dan hasilnya bersifat teoritis .

Tabel berikut menunjukkan penjualan pasar terbuka terbaru yang bukan bagian dari rencana perdagangan otomatis.

Tanggal Perdagangan Ticker Orang Dalam Dilaporkan
Saham
Dilaporkan
Harga
Disesuaikan
Saham
Disesuaikan
Harga
Dasar Biaya Hari-hari menuju
Menit
Harga di
Menit
Kerugian Maksimal
Dihindari ($)
Kerugian Maksimal
Dihindari (%)
2025-03-07 YMAB Gad Thomas 10,810 5.2300 10,810 5.2300 56,536 68 3.6400 -17,188 -30.40
2024-09-16 YMAB Gad Thomas 30,000 12.9700 30,000 12.9700 389,100
2024-09-13 YMAB Gad Thomas 65,000 13.4700 65,000 13.4700 875,550
2024-06-11 YMAB Gad Thomas 35,000 12.0000 35,000 12.0000 420,000
2024-06-10 YMAB Gad Thomas 35,000 12.0300 35,000 12.0300 421,050
2024-05-23 YMAB Gad Thomas 7,351 13.0000 7,351 13.0000 95,563
2024-05-21 YMAB Gad Thomas 25,000 12.0000 25,000 12.0000 300,000
2024-03-05 YMAB Gad Thomas 3,900 16.4400 3,900 16.4400 64,116
2023-12-15 YMAB Gad Thomas 50,000 6.6100 50,000 6.6100 330,500
2023-12-14 YMAB Gad Thomas 50,000 6.8300 50,000 6.8300 341,500
2023-12-13 YMAB Gad Thomas 50,000 6.5800 50,000 6.5800 329,000
2023-11-21 YMAB Gad Thomas 75,000 5.3065 75,000 5.3065 397,988
2023-11-20 YMAB Gad Thomas 75,000 5.2986 75,000 5.2986 397,395
2022-02-09 YMAB Gad Thomas 64,276 6.9562 64,276 6.9562 447,117
2022-02-08 YMAB Gad Thomas 125,863 7.0147 125,863 7.0147 882,891
2022-02-07 YMAB Gad Thomas 91,031 7.5928 91,031 7.5928 691,180
2022-02-04 YMAB Gad Thomas 101,104 7.7003 101,104 7.7003 778,531
2022-02-03 YMAB Gad Thomas 35,060 7.9015 35,060 7.9015 277,027
2022-01-24 YMAB Gad Thomas 32,272 10.0747 32,272 10.0747 325,131
2022-01-24 YMAB Gad Thomas 55,783 10.9582 55,783 10.9582 611,281
2022-01-21 YMAB Gad Thomas 50,134 10.5061 50,134 10.5061 526,713
2022-01-21 YMAB Gad Thomas 20,184 11.3507 20,184 11.3507 229,103
2022-01-20 YMAB Gad Thomas 112,767 11.3268 112,767 11.3268 1,277,289
2022-01-19 YMAB Gad Thomas 69,414 10.8925 69,414 10.8925 756,092
2022-01-18 YMAB Gad Thomas 400 11.4600 400 11.4600 4,584
2021-12-07 YMAB Gad Thomas 10,000 17.5832 10,000 17.5832 175,832
2021-12-06 YMAB Gad Thomas 40,000 16.4815 40,000 16.4815 659,260
2021-12-06 YMAB Gad Thomas 4,000 16.4955 4,000 16.4955 65,982
2021-11-30 YMAB Gad Thomas 600 16.9433 600 16.9433 10,166
2021-11-30 YMAB Gad Thomas 12,800 17.1052 12,800 17.1052 218,947
2021-11-30 YMAB Gad Thomas 7,770 17.0441 7,770 17.0441 132,433
2021-11-29 YMAB Gad Thomas 22,437 17.1603 22,437 17.1603 385,026
2021-11-23 YMAB Gad Thomas 50,000 17.0570 50,000 17.0570 852,850
2021-09-02 YMAB Gad Thomas 50,000 33.1783 50,000 33.1783 1,658,915
2021-08-17 YMAB Gad Thomas 1,779 28.9640 1,779 28.9640 51,527
2021-08-16 YMAB Gad Thomas 22,111 29.3305 22,111 29.3305 648,527
2021-08-13 YMAB Gad Thomas 1,110 31.0141 1,110 31.0141 34,426
2020-12-11 YMAB Gad Thomas 50,000 51.1728 50,000 51.1728 2,558,640
2020-12-10 YMAB Gad Thomas 50,000 50.7524 50,000 50.7524 2,537,620
2020-09-14 YMAB Gad Thomas 22,569 41.0043 22,569 41.0043 925,426
2020-09-11 YMAB Gad Thomas 13,571 40.3309 13,571 40.3309 547,331
2020-09-10 YMAB Gad Thomas 13,860 41.5844 13,860 41.5844 576,360
2020-08-12 YMAB Gad Thomas 13,000 39.5105 13,000 39.5105 513,636
2020-08-11 YMAB Gad Thomas 37,000 40.0552 37,000 40.0552 1,482,042
2020-05-27 YMAB Gad Thomas 50,000 39.0092 50,000 39.0092 1,950,460
2020-05-12 YMAB Gad Thomas 50,000 39.0387 50,000 39.0387 1,951,935
2019-04-11 YMAB Gad Thomas 150,000 25.8000 150,000 25.8000 3,870,000
2019-04-09 YMAB Gad Thomas 99,200 26.0200 99,200 26.0200 2,581,184
2019-04-09 YMAB Gad Thomas 800 26.9316 800 26.9316 21,545

Harga yang Disesuaikan adalah harga yang disesuaikan dengan pemisahan saham. Saham yang Disesuaikan adalah saham yang disesuaikan dengan pemisahan saham.

YMAB / Y-mAbs Therapeutics, Inc. Insider Trades
Sejarah Perdagangan Orang Dalam

Tabel ini menunjukkan daftar lengkap transaksi orang dalam yang dilakukan oleh Thomas Gad sebagaimana diungkapkan kepada Komisi Bursa Efek (Securities Exchange Commission/SEC).

Tanggal File Tanggal Transaksi Formulir Ticker Keamanan Kode 10b5-1 Saham Sisa Saham Persen
Ubah
Bagikan
Harga
Tran
Nilai
Sisa
Nilai
2025-06-05 2025-06-03 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
M - Exercise 103,000 305,721 50.81 2.00 206,000 611,442
2025-03-11 2025-03-07 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale -10,810 202,721 -5.06 5.23 -56,536 1,060,231
2025-01-22 2025-01-17 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
A - Award 32,000 213,531 17.63
2024-09-20 2024-09-19 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
M - Exercise 22,831 181,531 14.39 4.38 100,000 795,106
2024-09-17 2024-09-16 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale -30,000 67,681 -30.71 12.97 -389,100 877,823
2024-09-17 2024-09-13 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale -65,000 97,681 -39.96 13.47 -875,550 1,315,763
2024-06-11 2024-06-11 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale -35,000 162,681 -17.71 12.00 -420,000 1,952,172
2024-06-11 2024-06-10 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale -35,000 197,681 -15.04 12.03 -421,050 2,378,102
2024-05-23 2024-05-23 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale -7,351 232,681 -3.06 13.00 -95,563 3,024,853
2024-05-23 2024-05-21 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale -25,000 240,032 -9.43 12.00 -300,000 2,880,384
2024-03-07 2024-03-05 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale -3,900 158,700 -2.40 16.44 -64,116 2,609,028
2024-01-22 2024-01-18 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
A - Award 22,100 162,600 15.73
2023-12-26 2023-12-21 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
M - Exercise 50,000 140,500 55.25 2.00 100,000 281,000
2023-12-15 2023-12-15 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale -50,000 265,032 -15.87 6.61 -330,500 1,751,862
2023-12-15 2023-12-14 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale -50,000 315,032 -13.70 6.83 -341,500 2,151,669
2023-12-15 2023-12-13 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale -50,000 365,032 -12.05 6.58 -329,000 2,401,911
2023-11-22 2023-11-21 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale -75,000 415,032 -15.31 5.31 -397,988 2,202,367
2023-11-22 2023-11-20 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale -75,000 490,032 -13.27 5.30 -397,395 2,596,484
2023-01-19 2023-01-17 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
A - Award 40,500 90,500 81.00
2022-05-19 2022-05-18 4 YMAB Y-mAbs Therapeutics, Inc.
Employee Stock Option (right to buy)
A - Award 60,000 60,000
2022-02-09 2022-02-09 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale -64,276 565,032 -10.21 6.96 -447,117 3,930,476
2022-02-09 2022-02-08 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale -125,863 629,308 -16.67 7.01 -882,891 4,414,407
2022-02-09 2022-02-07 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale -91,031 755,171 -10.76 7.59 -691,180 5,733,862
2022-02-07 2022-02-04 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale -101,104 846,202 -10.67 7.70 -778,531 6,516,009
2022-02-07 2022-02-03 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale -35,060 947,306 -3.57 7.90 -277,027 7,485,138
2022-02-03 2022-02-01 4 YMAB Y-mAbs Therapeutics, Inc.
Employee Stock Option (right to buy)
M - Exercise -8,000 153,000 -4.97
2022-02-03 2022-02-01 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale X -8,000 50,000 -13.79 10.15 -81,161 507,255
2022-02-03 2022-02-01 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
M - Exercise 8,000 58,000 16.00 2.00 16,000 116,000
2022-01-26 2022-01-24 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale -55,783 982,366 -5.37 10.96 -611,281 10,764,963
2022-01-26 2022-01-24 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale -32,272 1,038,149 -3.01 10.07 -325,131 10,459,040
2022-01-24 2022-01-21 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale -20,184 1,070,421 -1.85 11.35 -229,103 12,150,028
2022-01-24 2022-01-21 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale -50,134 1,090,605 -4.39 10.51 -526,713 11,458,005
2022-01-24 2022-01-20 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale -112,767 1,140,739 -9.00 11.33 -1,277,289 12,920,923
2022-01-20 2022-01-19 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale -69,414 1,253,506 -5.25 10.89 -756,092 13,653,814
2022-01-20 2022-01-18 4 YMAB Y-mAbs Therapeutics, Inc.
Employee Stock Option (right to buy)
M - Exercise -8,000 161,000 -4.73
2022-01-20 2022-01-18 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale -400 1,322,920 -0.03 11.46 -4,584 15,160,663
2022-01-20 2022-01-18 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale X -8,000 50,000 -13.79 11.54 -92,314 576,965
2022-01-20 2022-01-18 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
M - Exercise 8,000 58,000 16.00 2.00 16,000 116,000
2021-12-16 2021-12-14 4 YMAB Y-mAbs Therapeutics, Inc.
Employee Stock Option (right to buy)
A - Award 110,000 110,000
2021-12-16 2021-12-14 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
G - Gift 60,000 1,383,320 4.53
2021-12-16 2021-12-14 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
G - Gift -60,000 1,323,320 -4.34
2021-12-08 2021-12-07 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale -10,000 1,383,320 -0.72 17.58 -175,832 24,323,192
2021-12-08 2021-12-06 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale -4,000 1,393,320 -0.29 16.50 -65,982 22,983,510
2021-12-08 2021-12-06 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale -40,000 1,397,320 -2.78 16.48 -659,260 23,029,930
2021-12-01 2021-11-30 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale X -4,000 1,437,320 -0.28 16.98 -67,912 24,402,963
2021-12-01 2021-11-30 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale -7,770 1,441,320 -0.54 17.04 -132,433 24,566,002
2021-12-01 2021-11-30 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale -12,800 1,449,090 -0.88 17.11 -218,947 24,786,974
2021-12-01 2021-11-30 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale -600 1,461,890 -0.04 16.94 -10,166 24,769,241
2021-12-01 2021-11-29 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale -22,437 1,462,490 -1.51 17.16 -385,026 25,096,767
2021-11-26 2021-11-23 4 YMAB Y-mAbs Therapeutics, Inc.
Employee Stock Option (right to buy)
M - Exercise -50,000 169,000 -22.83
2021-11-26 2021-11-23 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale -50,000 50,000 -50.00 17.06 -852,850 852,850
2021-11-26 2021-11-23 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
M - Exercise 50,000 100,000 100.00 2.00 100,000 200,000
2021-11-18 2021-11-16 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale X -4,000 1,484,927 -0.27 19.33 -77,302 28,696,957
2021-11-01 2021-10-29 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale X -4,000 1,488,927 -0.27 24.82 -99,261 36,948,021
2021-10-19 2021-10-15 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale X -4,000 1,492,927 -0.27 27.20 -108,799 40,607,316
2021-10-04 2021-09-30 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale X -4,000 1,496,927 -0.27 28.26 -113,054 42,308,546
2021-09-17 2021-09-15 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale X -4,000 1,500,927 -0.27 33.64 -134,579 50,498,239
2021-09-07 2021-09-07 4 YMAB Y-mAbs Therapeutics, Inc.
Employee Stock Option (right to buy)
M - Exercise -50,000 219,000 -18.59
2021-09-07 2021-09-07 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
M - Exercise 50,000 50,000 2.00 100,000 100,000
2021-09-07 2021-09-02 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale -50,000 1,504,927 -3.22 33.18 -1,658,915 49,930,919
2021-08-17 2021-08-17 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale -1,779 1,554,927 -0.11 28.96 -51,527 45,036,906
2021-08-17 2021-08-16 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale -22,111 1,556,706 -1.40 29.33 -648,527 45,658,965
2021-08-17 2021-08-16 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale X -4,000 1,578,817 -0.25 29.14 -116,544 46,000,412
2021-08-17 2021-08-13 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale -1,110 1,582,817 -0.07 31.01 -34,426 49,089,645
2021-08-05 2021-08-03 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale X -4,000 1,583,927 -0.25 33.73 -134,927 53,428,709
2021-07-21 2021-07-20 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale X -4,000 1,587,927 -0.25 32.47 -129,875 51,558,084
2021-07-08 2021-07-07 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale X -4,000 1,591,927 -0.25 31.87 -127,465 50,728,664
2021-07-02 2021-06-30 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale X -4,000 1,595,927 -0.25 33.86 -135,446 54,040,323
2021-06-15 2021-06-14 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale X -4,000 1,599,927 -0.25 35.80 -143,217 57,284,266
2021-06-01 2021-05-28 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale X -4,000 1,603,927 -0.25 36.95 -147,813 59,270,396
2021-05-20 2021-05-18 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale X -4,000 1,607,927 -0.25 34.07 -136,290 54,785,932
2021-04-28 2021-04-26 4 YMAB Y-mAbs Therapeutics, Inc.
Employee Stock Option (right to buy)
M - Exercise -7,000 269,000 -2.54
2021-04-28 2021-04-26 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale X -7,000 0 -100.00 27.96 -195,730
2021-04-28 2021-04-26 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
M - Exercise X 7,000 7,000 2.00 14,000 14,000
2021-04-14 2021-04-12 4 YMAB Y-mAbs Therapeutics, Inc.
Employee Stock Option (right to buy)
M - Exercise -7,000 276,000 -2.47
2021-04-14 2021-04-12 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale X -4,000 1,611,927 -0.25 26.60 -106,388 42,872,422
2021-04-14 2021-04-12 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale X -7,000 0 -100.00 26.61 -186,253
2021-04-14 2021-04-12 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
M - Exercise X 7,000 7,000 2.00 14,000 14,000
2021-04-05 2021-04-01 4 YMAB Y-mAbs Therapeutics, Inc.
Employee Stock Option (right to buy)
M - Exercise -9,000 283,000 -3.08
2021-04-05 2021-04-01 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale X -6,000 1,615,927 -0.37 30.27 -181,615 48,912,818
2021-04-05 2021-04-01 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale X -9,000 0 -100.00 30.26 -272,331
2021-04-05 2021-04-01 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
M - Exercise X 9,000 9,000 2.00 18,000 18,000
2021-03-17 2021-03-15 4 YMAB Y-mAbs Therapeutics, Inc.
Employee Stock Option (right to buy)
M - Exercise -7,000 292,000 -2.34
2021-03-17 2021-03-15 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale X -4,000 1,621,927 -0.25 36.78 -147,102 59,647,176
2021-03-17 2021-03-15 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale X -7,000 0 -100.00 36.79 -257,554
2021-03-17 2021-03-15 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
M - Exercise X 7,000 7,000 2.00 14,000 14,000
2021-03-12 2021-03-10 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
J - Other 1,029,927 1,625,927 172.81
2021-03-03 2021-03-01 4 YMAB Y-mAbs Therapeutics, Inc.
Employee Stock Option (right to buy)
M - Exercise -9,000 299,000 -2.92
2021-03-03 2021-03-01 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale X -6,000 596,000 -1.00 35.50 -213,029 21,160,861
2021-03-03 2021-03-01 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale X -9,000 0 -100.00 35.51 -319,611
2021-03-03 2021-03-01 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
M - Exercise X 9,000 9,000 2.00 18,000 18,000
2021-02-18 2021-02-16 4 YMAB Y-mAbs Therapeutics, Inc.
Employee Stock Option (right to buy)
M - Exercise -7,000 308,000 -2.22
2021-02-18 2021-02-16 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale X -4,000 602,000 -0.66 47.09 -188,367 28,349,203
2021-02-18 2021-02-16 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale X -7,000 0 -100.00 47.08 -329,556
2021-02-18 2021-02-16 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
M - Exercise X 7,000 7,000 2.00 14,000 14,000
2021-02-03 2021-02-01 4 YMAB Y-mAbs Therapeutics, Inc.
Employee Stock Option (right to buy)
M - Exercise -7,000 315,000 -2.17
2021-02-03 2021-02-01 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale X -4,000 606,000 -0.66 41.97 -167,888 25,435,032
2021-02-03 2021-02-01 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale X -7,000 0 -100.00 41.99 -293,897
2021-02-03 2021-02-01 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
M - Exercise X 7,000 7,000 2.00 14,000 14,000
2021-01-21 2021-01-19 4 YMAB Y-mAbs Therapeutics, Inc.
Employee Stock Option (right to buy)
M - Exercise -7,000 322,000 -2.13
2021-01-21 2021-01-19 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale X -4,000 610,000 -0.65 46.56 -186,230 28,400,136
2021-01-21 2021-01-19 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale X -7,000 0 -100.00 46.51 -325,563
2021-01-21 2021-01-19 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
M - Exercise X 7,000 7,000 2.00 14,000 14,000
2021-01-07 2021-01-05 4 YMAB Y-mAbs Therapeutics, Inc.
Employee Stock Option (right to buy)
M - Exercise -7,000 329,000 -2.08
2021-01-07 2021-01-05 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale X -4,000 614,000 -0.65 49.31 -197,248 30,277,568
2021-01-07 2021-01-05 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale X -7,000 0 -100.00 49.36 -345,509
2021-01-07 2021-01-05 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
M - Exercise X 7,000 7,000 2.00 14,000 14,000
2020-12-30 2020-12-28 4 YMAB Y-mAbs Therapeutics, Inc.
Employee Stock Option (right to buy)
M - Exercise -7,000 336,000 -2.04
2020-12-30 2020-12-28 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale X -7,000 0 -100.00 51.98 -363,833
2020-12-30 2020-12-28 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
M - Exercise X 7,000 7,000 2.00 14,000 14,000
2020-12-17 2020-12-16 4 YMAB Y-mAbs Therapeutics, Inc.
Employee Stock Option (right to buy)
M - Exercise -7,000 343,000 -2.00
2020-12-17 2020-12-16 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale X -7,000 0 -100.00 53.01 -371,065
2020-12-17 2020-12-16 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
M - Exercise X 7,000 7,000 2.00 14,000 14,000
2020-12-16 2020-12-14 4 VYMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale X -4,000 618,000 -0.64 52.89 -211,546 32,683,795
2020-12-16 2020-12-15 4 YMAB Y-mAbs Therapeutics, Inc.
Employee Stock Option (right to buy)
A - Award 91,450 91,450
2020-12-14 2020-12-11 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale -50,000 0 -100.00 51.17 -2,558,640
2020-12-14 2020-12-11 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
M - Exercise 50,000 50,000 2.00 100,000 100,000
2020-12-14 2020-12-10 4 YMAB Y-mAbs Therapeutics, Inc.
Employee Stock Option (right to buy)
M - Exercise -50,000 350,000 -12.50
2020-12-14 2020-12-10 4 YMAB Y-mAbs Therapeutics, Inc.
Employee Stock Option (right to buy)
M - Exercise -50,000 350,000 -12.50
2020-12-14 2020-12-10 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale -50,000 0 -100.00 50.75 -2,537,620
2020-12-14 2020-12-10 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
M - Exercise 50,000 50,000 2.00 100,000 100,000
2020-12-02 2020-12-01 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale X -4,000 622,000 -0.64 51.42 -205,685 31,984,049
2020-11-17 2020-11-16 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale X -4,000 626,000 -0.63 46.17 -184,672 28,901,105
2020-11-05 2020-11-02 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale X -4,000 630,000 -0.63 43.69 -174,769 27,526,086
2020-10-19 2020-10-15 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale X -4,000 634,000 -0.63 39.15 -156,604 24,821,671
2020-10-02 2020-10-01 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale X -4,000 638,000 -0.62 38.88 -155,524 24,806,142
2020-09-17 2020-09-15 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale X -4,000 642,000 -0.62 40.81 -163,225 26,197,580
2020-09-15 2020-09-14 4 YMAB Y-mAbs Therapeutics, Inc.
Employee Stock Option (right to buy)
M - Exercise -22,569 450,000 -4.78
2020-09-15 2020-09-14 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale -22,569 0 -100.00 41.00 -925,426
2020-09-15 2020-09-14 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
M - Exercise 22,569 22,569 2.00 45,138 45,138
2020-09-15 2020-09-11 4 YMAB Y-mAbs Therapeutics, Inc.
Employee Stock Option (right to buy)
M - Exercise -13,571 472,569 -2.79
2020-09-15 2020-09-11 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale -13,571 0 -100.00 40.33 -547,331
2020-09-15 2020-09-11 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
M - Exercise 13,571 13,571 2.00 27,142 27,142
2020-09-15 2020-09-10 4 YMAB Y-mAbs Therapeutics, Inc.
Employee Stock Option (right to buy)
M - Exercise -13,860 486,140 -2.77
2020-09-15 2020-09-10 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale -13,860 0 -100.00 41.58 -576,360
2020-09-15 2020-09-10 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
M - Exercise 13,860 13,860 2.00 27,720 27,720
2020-09-02 2020-09-01 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale X -4,000 646,000 -0.62 41.60 -166,390 26,872,050
2020-08-19 2020-08-17 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale X -4,000 650,000 -0.61 40.35 -161,392 26,226,200
2020-08-13 2020-08-12 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale -13,000 654,000 -1.95 39.51 -513,636 25,839,867
2020-08-13 2020-08-11 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale -37,000 667,000 -5.26 40.06 -1,482,042 26,716,818
2020-08-05 2020-08-03 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale X -4,000 704,000 -0.56 36.51 -146,026 25,700,576
2020-07-17 2020-07-15 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale X -4,000 708,000 -0.56 40.06 -160,229 28,360,568
2020-07-06 2020-07-01 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale X -4,000 712,000 -0.56 42.04 -168,178 29,935,684
2020-06-16 2020-06-15 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale X -4,000 716,000 -0.56 43.45 -173,811 31,112,205
2020-06-05 2020-06-04 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale X -4,000 720,000 -0.55 41.61 -166,444 29,959,848
2020-05-29 2020-05-27 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale -50,000 724,000 -6.46 39.01 -1,950,460 28,242,661
2020-05-20 2020-05-18 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale X -4,000 774,000 -0.51 39.65 -158,596 30,688,326
2020-05-14 2020-05-12 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale -50,000 778,000 -6.04 39.04 -1,951,935 30,372,109
2020-05-05 2020-05-01 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale X -4,000 828,000 -0.48 32.35 -129,404 26,786,711
2020-04-15 2020-04-13 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale X -4,000 832,000 -0.48 29.43 -117,711 24,483,930
2020-03-18 2020-03-16 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale X -4,000 836,000 -0.48 18.01 -72,041 15,056,527
2020-03-04 2020-03-02 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale X -4,000 840,000 -0.47 29.18 -116,713 24,509,772
2020-02-20 2020-02-18 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale X -4,000 844,000 -0.47 32.78 -131,133 27,669,021
2020-02-11 2020-02-10 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale X -4,000 848,000 -0.47 33.03 -132,121 28,009,610
2020-01-29 2020-01-27 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale X -4,000 852,000 -0.47 35.06 -140,224 29,867,627
2020-01-15 2020-01-13 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale X -4,000 856,000 -0.47 30.90 -123,612 26,452,968
2020-01-09 2020-01-07 4 YMAB Y-mAbs Therapeutics, Inc.
Employee Stock Option (right to buy)
A - Award 130,000 130,000
2019-12-31 2019-12-30 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
J - Other -201 1,030,356 -0.02
2019-12-17 2019-12-16 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale X -4,000 860,000 -0.46 31.54 -126,176 27,127,926
2019-12-17 2019-12-13 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
G - Gift -8,000 864,000 -0.92
2019-12-04 2019-12-02 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale X -4,000 872,000 -0.46 32.48 -129,930 28,324,827
2019-11-19 2019-11-18 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale X -4,000 876,000 -0.45 28.41 -113,658 24,891,014
2019-11-05 2019-11-04 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale X -4,000 880,000 -0.45 30.10 -120,418 26,491,960
2019-10-22 2019-10-21 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale X -4,000 884,000 -0.45 27.59 -110,351 24,387,527
2019-10-08 2019-10-07 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale X -4,000 888,000 -0.45 25.21 -100,848 22,388,256
2019-09-17 2019-09-16 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale X -4,000 892,000 -0.45 30.59 -122,376 27,289,759
2019-09-05 2019-09-03 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale X -4,000 896,000 -0.44 25.77 -103,081 23,090,099
2019-08-20 2019-08-19 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale X -4,000 900,000 -0.44 27.70 -110,805 24,931,080
2019-08-06 2019-08-05 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale X -4,000 904,000 -0.44 21.78 -87,106 19,685,866
2019-07-23 2019-07-22 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale X -4,000 908,000 -0.44 22.54 -90,177 20,470,134
2019-07-10 2019-07-08 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale X -4,000 912,000 -0.44 22.40 -89,592 20,426,885
2019-06-25 2019-06-24 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale X -4,000 916,000 -0.43 21.77 -87,098 19,945,350
2019-06-11 2019-06-10 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale X -4,000 920,000 -0.43 22.79 -91,166 20,968,272
2019-06-04 2019-06-03 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale X -4,000 924,000 -0.43 20.03 -80,121 18,507,997
2019-05-29 2019-05-28 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale X -6,000 928,000 -0.64 20.21 -121,252 18,753,674
2019-05-14 2019-05-13 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale X -6,000 934,000 -0.64 20.61 -123,647 19,247,779
2019-04-11 2019-04-11 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale -150,000 940,000 -13.76 25.80 -3,870,000 24,252,000
2019-04-11 2019-04-09 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale -800 1,090,000 -0.07 26.93 -21,545 29,355,444
2019-04-11 2019-04-09 4 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
S - Sale -99,200 1,090,800 -8.34 26.02 -2,581,184 28,382,616
2018-12-13 2018-12-11 4 YMAB Y-mAbs Therapeutics, Inc.
Employee Stock Option (right to buy)
A - Award 107,500 107,500
2018-09-20 3 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
3,410,557
2018-09-20 3 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
3,251,114
2018-09-20 3 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
3,410,557
2018-09-20 3 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
3,251,114
2018-09-20 3 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
3,410,557
2018-09-20 3 YMAB Y-mAbs Therapeutics, Inc.
Common Stock
3,251,114
P
Pembelian sekuritas non-derivatif atau derivatif di pasar terbuka atau secara pribadi.
S
Penjualan terbuka atau penjualan pribadi atas sekuritas non-derivatif atau derivatif.
A
Hibah, penghargaan, atau perolehan sekuritas lainnya dari perusahaan (seperti opsi)
C
Konversi turunan
D
Penjualan atau pengalihan sekuritas kembali ke perusahaan.
F
Pembayaran harga pelaksanaan atau kewajiban pajak menggunakan sebagian sekuritas yang diterima dari perusahaan.
G
Pemberian sekuritas oleh atau kepada orang dalam.
K
Swap ekuitas dan transaksi lindung nilai serupa
M
Pelaksanaan atau konversi sekuritas derivatif yang diterima dari perusahaan (seperti opsi)
V
Transaksi yang dilaporkan secara sukarela pada Formulir 4.
J
Lainnya (disertai dengan catatan kaki yang menjelaskan transaksi tersebut)